C3 and systemic lupus erythematosus: An increase in iC3b and other C3 fragments may contribute to complement-driven immune activation in diseases such as systemic lupus erythematosus (SLE) where patients have reduced levels of CR1 in erythrocytes (Iida et al., 1982).